Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life AnalysisEleni Gavriilaki, Ioanna Sakellari, Panagiotis Dolgyras et al.|Cancers|2023Cited by 19
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell RecipientsEleni Gavriilaki, Ioannis Papassotiriou, Christos Demosthenous et al.|International Journal of Molecular Sciences|2024Cited by 9
Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World ExperienceEleni Gavriilaki, Ioanna Sakellari, D. Mallouri et al.|Cancers|2023Cited by 6
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell RecipientsEleni Gavriilaki, Ioannis Papassotiriou, Christos Demosthenous et al.|Blood|2024Cited by 0
Evaluation of Cognitive Impairment and Neurotoxicity Post CAR-T Cell Therapy.Evlampia Strongyli, Ioanna Sakellari, Eleni Gavriilaki et al.|Transplantation and Cellular Therapy|2025Cited by 0